Efficacy News and Research

RSS

Study on SARS-CoV-2 Delta breakthrough infections shows twice the risk as Alpha

A recent study conducted by Portuguese scientists has claimed that mRNA-based coronavirus disease 2019 (COVID-19) vaccines are less effective against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, in breakthrough infections by delta variant, vaccines are less effective in reducing viral loads. The study is currently available on the medRxiv* preprint server.

25 Aug 2021

Reassuring news about the protection that SARS-CoV-2 vaccines offer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have proven effective at preventing COVID-19-related mortality and illness. Since no vaccine is 100% effective, breakthrough infections are likely to occur. New research by a group of scientists at Erasmus Medical Center and Radboud University in the Netherlands looked at vaccine-breakthrough infections in a large group of vaccinated healthcare workers (HCWs).

25 Aug 2021

Study finds a new line of drugs to stimulate myelin repair in multiple sclerosis

In the nearly 1 million Americans living with multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system—called myelin—is damaged.

24 Aug 2021

Psychological capital helps employees to cope with the negative effects of working in a pandemic

Just like the COVID-19 vaccine protects against contracting the contagious virus, the collective elements of self-efficacy, optimism, hope and resiliency helps inoculate employees from the negative effects of working through a pandemic, according to a new West Virginia University study.

24 Aug 2021

Glycyrrhizic acid as a drug candidate for COVID-19

A new study presents the benefits of licorice, an age-old herbal remedy, to treat COVID-19 at all stages.

24 Aug 2021

UCLA scientists receive $1 million translational award to advance CAR T cell therapy for rare melanomas

Scientists Dr. Cristina Puig-Saus and Dr. Daniel Shin from the UCLA Jonsson Comprehensive Cancer Center have received a $1 million Translational Research Award from the U.S. Department of Defense Melanoma Research Program to help advance the use of chimeric antigen receptor, or CAR, T cell therapy as a treatment for people with acral, mucosal and uveal melanomas.

24 Aug 2021

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

A new clinical trial to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems is launching in the UK.

24 Aug 2021

Study shows difference in antibody levels in response to SARS-CoV-2 infection and type of vaccination

In a recent study, researchers aimed to monitor the levels of the anti-SARS-CoV-2 spike IgG levels in populations that were subjected to routine tests.

24 Aug 2021

Which interventions can help prevent SARS-CoV-2's spread in schools?

A new preprint on the medRxiv* server shows that leaving the windows open all day is the most effective intervention.

24 Aug 2021

Higher vaccination coverage is associated with lower COVID-19 incidence and hospitalization

A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).

24 Aug 2021

Study suggests a novel therapeutic target to reverse lung fibrosis

Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.

24 Aug 2021

Synthetic SARS-CoV-2 vs. SARS-CoV-2

Though vaccination efforts are underway in most countries, there are still limited options for treating COVID-19. Now, researchers at Penn State designed a new COVID-19 therapy that uses a defective synthetic version of the SARS-CoV-2 virus to interfere with the actual virus's replication.

23 Aug 2021

Study discovers lagging chromosomes as one of the major causes of infertility

Why do women over 35 have more difficulty getting pregnant? After discovering one of the causes of age-related female infertility, researchers at the University of Montreal Hospital Research Centre suggest that it will be possible in the future to improve the quality of the eggs of older patients by intervening on the cell cycle level.

23 Aug 2021

CUNY SPH and NYC Health Department receive grant to study long-acting injectables for HIV

The National Institute of Mental Health has awarded the CUNY Graduate School of Public Health and Health Policy and the New York City Department of Health and Mental Hygiene a thirty month grant to support long-acting injectable antiretroviral therapy access, uptake, and adherence among people with HIV enrolled in the Ryan White HIV/AIDS Program (hereafter "Ryan White").

23 Aug 2021

FDA approves COVID-19 mRNA vaccine that uses fundamental Penn technology

The U.S. Food and Drug Administration has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists in the Perelman School of Medicine at the University of Pennsylvania, whose years of research in mRNA science laid a critical piece of the foundation for the largest global vaccination campaign in history.

23 Aug 2021

Efficacy News and Research

Study on SARS-CoV-2 Delta breakthrough infections shows twice the risk as Alpha

Reassuring news about the protection that SARS-CoV-2 vaccines offer

Study finds a new line of drugs to stimulate myelin repair in multiple sclerosis

Psychological capital helps employees to cope with the negative effects of working in a pandemic

Glycyrrhizic acid as a drug candidate for COVID-19

UCLA scientists receive $1 million translational award to advance CAR T cell therapy for rare melanomas

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

Study shows difference in antibody levels in response to SARS-CoV-2 infection and type of vaccination

Which interventions can help prevent SARS-CoV-2's spread in schools?

Higher vaccination coverage is associated with lower COVID-19 incidence and hospitalization

Study suggests a novel therapeutic target to reverse lung fibrosis

Synthetic SARS-CoV-2 vs. SARS-CoV-2

Study discovers lagging chromosomes as one of the major causes of infertility

CUNY SPH and NYC Health Department receive grant to study long-acting injectables for HIV

FDA approves COVID-19 mRNA vaccine that uses fundamental Penn technology

New study identifies novel compound as promising pan-coronavirus drug candidate

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

Study examines COVID vaccination in California state prisons

Therapeutic-dose anticoagulation benefits moderately ill COVID-19 patients

Researchers create a novel strategy for developing an effective TB vaccine

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News